AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

CVKD · NASDAQ · Biotechnology

Cadrenal Therapeutics

Developer of anticoagulation candidates for high-risk hospital and cardiovascular care.

$1.41

Pre-market−0.34 (−19.21%)

At close$1.75(+13.31%)

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions17 holders · as of Mar 31, 2026	2.55%	90.9K shares
Insiders2 holders · as of Jul 1, 2026	2.81%	100.3K shares
Otherremainder	94.64%	3.38M shares

3.57M company shares as of Sep 1, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Quang X. PhamInsiderdirector, 10 percent owner, officer: Chairman and CEO	2.76%	98,589	Form 4filed Jul 1, 2026 ↗
Vanguard Capital Management LLCInstitution	1.27%	45,201	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.61%	21,626	13Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution	0.23%	8,311	13Fas of Mar 31, 2026
JPMorgan Chase & CoInstitution	0.21%	7,500	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	0.15%	5,496	13Fas of Mar 31, 2026
Lee Scott GoldenInsiderdirector	0.05%	1,667	Form 4filed Dec 3, 2025 ↗
Institution	0.04%	1,492	13Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution	0.01%	393	13Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution	0.01%	300	13Fas of Mar 31, 2026
Destiny Wealth Partners, LLCInstitution	0.01%	200	13Fas of Mar 31, 2026
Rockefeller Capital Management L.P.Institution	0.00%	150	13Fas of Mar 31, 2026
Morgan StanleyInstitution	0.00%	100	13Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution	0.00%	99	13Fas of Mar 31, 2026
Archer Investment CorpInstitution	0.00%	35	13Fas of Mar 31, 2026
Ifp Advisors, IncInstitution	0.00%	30	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.00%	3	13Fas of Mar 31, 2026
Citigroup IncInstitution	0.00%	1	13Fas of Mar 31, 2026
Curio Wealth, LLCInstitution	0.00%	1	13Fas of Mar 31, 2026
Armistice Capital, LLCStrategic	—9.99% of class, as filed	—	13D/Gfiled Feb 14, 2024 ↗
Matthew K. SzotInsiderofficer: Chief Financial Officer	0.00%	0	Form 4filed Dec 31, 2025 ↗
John Raymond Murphy^1,2Insiderdirector	1.15%	40,986	Form 4filed Oct 6, 2023 ↗
Glynn Wilson³Insiderdirector	0.09%	3,333	Form 4filed Jan 24, 2023 ↗
Steven Zelenkofske⁴Insiderdirector	0.07%	2,667	Form 4filed Jan 19, 2023 ↗

Last filed Oct 6, 2023; leaving the company requires no filing. Not in the bar.
Reported at 2.96% on Jan 15, 2025, under the 5% line, so no further filing is required.
Last filed Jan 24, 2023; leaving the company requires no filing. Not in the bar.
Last filed Jan 19, 2023; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

17 holders · 90.9K shares · 5 new positions · 7 increased · 5 reduced · 6 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Vanguard Capital Management LLC	45.2K	1.27%	+45.2Knew	May 15, 2026
Geode Capital Management, LLC	21.6K	0.61%	+7.1K	May 15, 2026
Vanguard Fiduciary Trust Co	8.3K	0.23%	+8.3Knew	May 8, 2026
JPMorgan Chase & Co	7.5K	0.21%	0	May 13, 2026
BlackRock, Inc.	5.5K	0.15%	+2.0K	May 13, 2026
	1.5K	0.04%	+1.5Knew	May 13, 2026
Tower Research Capital LLC (TRC)	393	0.01%	−139	May 15, 2026
Advisor Group Holdings, Inc.	300	0.01%	−200	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Quang X. Phamincl. The PVBQ Living Trust	23.60%	421.0K	13D	Jan 29, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jun 29, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman and CEO	Sale	7,400	$3.03	98,589
Jun 26, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	9,029	$3.05	105,989
Jun 25, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	2,127	$3.00	115,018
Jun 23, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	2,277	$3.20	117,145
Jun 22, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	9,167	$3.55	119,422
Jun 17, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	513	$3.16	128,589
Jun 16, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	3,613	$3.18	129,102
Jun 15, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	3,666	$3.58	132,715
Jun 12, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	12,996	$3.94	136,381
Jun 11, 2026	Quang X. Phamdirector, 10 percent owner, officer: Chairman, CEO and Interim CFO	Sale	1,462	$4.12	149,377

CongressHouse and Senate disclosures

Not reported.